Other Clinical Trial - Study to Monitor Subcutaneous Human Immunoglobulin

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03266640` - Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)	Phase 2
Recruiting	`NCT03266627` - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection	Phase 2
Completed	`NCT01859754` - Octagam 5% Versus Comparator Post Marketing Trial
Recruiting	`NCT03148028` - Immunological Characteristics of Patients With PID and IBD	N/A
Active, not recruiting	`NCT04354818` - Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Completed	`NCT03988426` - Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases	Phase 3
Completed	`NCT01888484` - Study of Octanorm Subcutaneous IG in Patients With PID	Phase 3
Completed	`NCT01131858` - Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency	Phase 1/Phase 2
Completed	`NCT03211689` - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease	N/A
Terminated	`NCT01883921` - Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Recruiting	`NCT03266653` - EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection	Phase 2
Completed	`NCT02327351` - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID	Phase 2/Phase 3
Completed	`NCT03618147` - Primary Immunodeficiency in Kuwait
Recruiting	`NCT04197596` - Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)	Phase 1/Phase 2
Recruiting	`NCT03422614` - Pathophysiology of Inborn Immunodeficiencies	N/A
Completed	`NCT02888535` - Intensive Care Unit and Secondary and Primary Immune Deficiency
Recruiting	`NCT04232085` - Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide	Phase 2
Active, not recruiting	`NCT03037359` - A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
Completed	`NCT03069079` - Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study	N/A
Recruiting	`NCT03414528` - Identification of New Inborn Errors of Immunity	N/A

NCT number	NCT03939533
Study type	Interventional
Source	Octapharma
Contact
Status	Completed
Phase	Phase 3
Start date	October 17, 2019
Completion date	January 3, 2022

Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms